Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.

To determine the downstream signaling pathways regulated by betacellulin (BTC) in comparison with epidermal growth factor (EGF), we used Chinese hamster ovary cells overexpressing the human EGF receptor (ErbB1/EGFR). The overall time-dependent activation of EGFR autophosphorylation was identical in cells treated with 1 nm BTC or 1.5 nm EGF. Analysis of site-specific EGFR phosphorylation demonstrated that the BTC and EGF tyrosine phosphorylation of Y1086 was not significantly different. In contrast, the autophosphorylation of Y1173 was markedly reduced in BTC-stimulated cells, compared with EGF stimulation that directly correlated with a reduced BTC stimulation of Shc tyrosine phosphorylation, Ras, and Raf-1 activation. On the other hand, Y1068 phosphorylation was significantly increased after BTC stimulation, compared with EGF in parallel with a greater extent of Erk phosphorylation. Expression of a dominant interfering MEK kinase 1 (MEKK1) and Y1068F EGFR more efficiently blocked the enhanced Erk activation by BTC, compared with EGF. Interestingly BTC had a greater inhibitory effect on apoptosis, compared with EGF, and expression of Y1068F EGFR abolished this enhanced inhibitory effect. Together, these data indicated that although BTC and EGF share overlapping signaling properties, the ability of BTC to enhance Erk activation occurs independent of Ras. The increased BTC activation results from a greater extent of Y1068 EGFR tyrosine phosphorylation and subsequent increased recruitment of the Grb2-MEKK1 complex to the plasma membrane, compared with EGF stimulation. The increased Erk activation by BTC associated with antiapoptotic function.

[1]  J. Voorhees,et al.  Epidermal Growth Factor Receptor-dependent, NF-κB-independent Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Inhibits Ultraviolet Irradiation-induced Caspases-3, -8, and -9 in Human Keratinocytes* , 2003, Journal of Biological Chemistry.

[2]  P. Bertics,et al.  A Carboxyl-terminal Mutation of the Epidermal Growth Factor Receptor Alters Tyrosine Kinase Activity and Substrate Specificity as Measured by a Fluorescence Polarization Assay* , 2003, Journal of Biological Chemistry.

[3]  P. Clarke,et al.  Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK , 2003, Nature Cell Biology.

[4]  J. Carlsson,et al.  EGF and dextran-conjugated EGF induces differential phosphorylation of the EGF receptor. , 2002, International journal of molecular medicine.

[5]  W. Kolch,et al.  Regulation of Raf‐1 activation and signalling by dephosphorylation , 2002, The EMBO journal.

[6]  M. Seno,et al.  Promotion of β-Cell Regeneration by Betacellulin in Ninety Percent-Pancreatectomized Rats. , 2001, Endocrinology.

[7]  Edward S. Kim,et al.  Epidermal growth factor receptor biology (IMC-C225) , 2001, Current opinion in oncology.

[8]  T. Jovin,et al.  Heterogeneity of signal transduction at the subcellular level: microsphere-based focal EGF receptor activation and stimulation of Shc translocation. , 2001, Journal of cell science.

[9]  R. Scharfmann,et al.  Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. , 2001, Diabetes.

[10]  E. Lander,et al.  Growth Factor-specific Signaling Pathway Stimulation and Gene Expression Mediated by ErbB Receptors* 210 , 2001, The Journal of Biological Chemistry.

[11]  A. Verkleij,et al.  Peroxynitrite activates mitogen‐activated protein kinase (MAPK) via a MEK‐independent pathway: a role for protein kinase C , 2001, FEBS letters.

[12]  M. Kazanietz,et al.  Constitutive ERK1/2 Activation in Esophagogastric Rib Bone Marrow Micrometastatic Cells Is MEK-independent* , 2001, The Journal of Biological Chemistry.

[13]  L. Chaudhary,et al.  The cell survival signal Akt is differentially activated by PDGF‐BB, EGF, and FGF‐2 in osteoblastic cells , 2001, Journal of cellular biochemistry.

[14]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[15]  S. Bishayee.  Role of conformational alteration in the epidermal growth factor receptor (EGFR) function. , 2000, Biochemical pharmacology.

[16]  L. Cantley,et al.  Ligand Discrimination in Signaling through an ErbB4 Receptor Homodimer* , 2000, The Journal of Biological Chemistry.

[17]  J. Brugge,et al.  Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers , 1999, Molecular and Cellular Biology.

[18]  G L Johnson,et al.  Organization and regulation of mitogen-activated protein kinase signaling pathways. , 1999, Current opinion in cell biology.

[19]  M. Sliwkowski,et al.  Binding specificities and affinities of egf domains for ErbB receptors , 1999, FEBS letters.

[20]  C. Venot,et al.  Grb2 Interaction with MEK-Kinase 1 Is Involved in Regulation of Jun-Kinase Activities in Response to Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.

[21]  M. Kanzaki,et al.  Studies on the betacellulin receptor in pancreatic AR42J cells , 1998, Diabetologia.

[22]  M. Foschi,et al.  Biphasic activation of p21ras by endothelin‐1 sequentially activates the ERK cascade and phosphatidylinositol 3‐kinase , 1997, The EMBO journal.

[23]  P. Fedi,et al.  Epidermal growth factor and betacellulin mediate signal transduction through co‐expressed ErbB2 and ErbB3 receptors , 1997, The EMBO journal.

[24]  B. Ohlsson,et al.  Epidermal Growth Factor Induces Cell Proliferation in Mouse Pancreas and Salivary Glands , 1997, Pancreas.

[25]  J. Pessin,et al.  Interactions between Src Homology (SH) 2/SH3 Adapter Proteins and the Guanylnucleotide Exchange Factor SOS Are Differentially Regulated by Insulin and Epidermal Growth Factor* , 1996, The Journal of Biological Chemistry.

[26]  N. Hynes,et al.  Epidermal Growth Factor-related Peptides Activate Distinct Subsets of ErbB Receptors and Differ in Their Biological Activities (*) , 1996, The Journal of Biological Chemistry.

[27]  C. Ward,et al.  Systematic Mapping of Potential Binding Sites for Shc and Grb2 SH2 Domains on Insulin Receptor Substrate-1 and the Receptors for Insulin, Epidermal Growth Factor, Platelet-derived Growth Factor, and Fibroblast Growth Factor (*) , 1996, The Journal of Biological Chemistry.

[28]  T. van Raaij,et al.  Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. , 1996, Oncogene.

[29]  J. Pessin,et al.  Shc Isoform-specific Tyrosine Phosphorylation by the Insulin and Epidermal Growth Factor Receptors (*) , 1995, The Journal of Biological Chemistry.

[30]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[31]  J. Olefsky,et al.  The signaling pathway coupling epidermal growth factor receptors to activation of p21ras. , 1994, The Journal of biological chemistry.

[32]  J. Schlessinger,et al.  Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor , 1994, Molecular and cellular biology.

[33]  L. Cantley,et al.  A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling , 1994, Cell.

[34]  B. Wainer,et al.  Activation of Mitogen‐Activated Protein Kinase by Epidermal Growth Factor in Hippocampal Neurons and Neuronal Cell Lines , 1993, Journal of neurochemistry.

[35]  Julian Downward,et al.  Epidermal growth factor regulates p21 ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor , 1993, Cell.

[36]  D. Hanahan,et al.  Betacellulin: a mitogen from pancreatic beta cell tumors. , 1993, Science.

[37]  Sheila M. Thomas,et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.

[38]  C. Crews,et al.  The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. , 1992, Science.

[39]  David L. Brautigan,et al.  Raf-1 activates MAP kinase-kinase , 1992, Nature.

[40]  K A Overholser,et al.  Multiple autophosphorylation site mutations of the epidermal growth factor receptor. Analysis of kinase activity and endocytosis. , 1991, The Journal of biological chemistry.

[41]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[42]  J. Folkman,et al.  Human betacellulin, a member of the EGF family dominantly expressed in pancreas and small intestine, is fully active in a monomeric form. , 1996, Growth factors.